Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity

NCT05535322 · clinicaltrials.gov ↗

COMPLETED

Status

26944

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Obesity

Interventions

DRUG: GLP-1RA
DRUG: SGLT2i
DRUG: Insulin
DRUG: Miscellany

Sponsor

Ana Palanca